Ablation is a minimally invasive procedure to treat abnormal electrical short circuits caused by a heart attack. These ...

From its cardiovascular divisions, Medtronic brought in $3.10 billion for an increase of 6.1%—driven in part by the launches ...

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Rapid commercialization of new treatments for atrial fibrillation and sales of diabetes devices help revenue climb 5%.

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation (OAC) therapy for reducing the risk of long-term bleeding ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...

A new study reveals a concerning trend: bowel cancer deaths among Millennials and Gen Xers in Europe are projected to rise.